Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

48

Revenue 2017

Crestor

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Crestor was produced by AstraZeneca and Shionogi.

Bayer sues Glenmark over its skin disorder generic

Bayer sues Glenmark over its skin disorder generic The lawsuit comes three months after Glenmark was one of several generic companies to lose a challenge against AstraZeneca, which had its patent for cholesterol drug Crestor upheld by an appeals

AZ loses Crestor patent battle in Australia

AZ loses Crestor patent battle in Australia The ruling in Australia follows a victory for AZ in the defense of Crestor's IP in the US. ... Given Crestor's importance to the group … we believe this increases pressure on management to undertake some sort of M&A," said Neophytou.

Building brand strength – Part 4

Building brand strength – Part 4 When AstraZeneca's cholesterol-lowering statin, Crestor launched, Lipitor directly adapted to the market changes by evolving and repositioning its brand in Europe. ... Your Decision' campaign targeted towards healthcare professionals. This allowed

Three new members at ABPI

Three new members at ABPI Shionogi is a Japan-based pharma firm that is perhaps best known for discovering the blockbuster statin Crestor (rosuvostatin).

Shionogi: an expanding commercial focus

Shionogi: an expanding commercial focus Perhaps best known for being the company that discovered the blockbuster statin Crestor (rosuvostatin), Shionogi has largely restricted its global focus to R&D. ... Shionogi doesn't yet market its own products in Europe. Outside Japan Crestor is sold by

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...